Liyanage Lab

Thrilled to share our work on innate immune cells and cardiovascular risk in COVID-19 is featured in the latest issue editorial! Huge thanks to everyone involved! https://www.ahajournals.org/doi/10.1161/ATVBAHA.124.321085

Scientists from The Peter Doherty Institute for Infection and Immunity, The Alfred, Monash University now have a clearer picture of how T cells discriminate between self-antigen and foreign antigens, highlighting the role of NK cell receptors in helping T cells fight viruses and prevent autoimmunity.

Learn more here: https://fcld.ly/7o8ltgg

The primary focus of our laboratory is to understand the host-pathogen interactions and to use this knowledge to develop therapeutics and preventive vaccines for viral infections such as HIV. We are currently focusing on;

(1) Understanding the role of innate immune cells (NK/ILC/monocytes) in HIV/SIV pathogenesis and preventive vaccines

(2) Investigating the role of innate immunity in HIV/TB co-infection and BCG vaccination.

(3) Studying the Immunopathogenesis of SARS-CoV-2, COVID-19-associated cardiometabolic complications, and the development of therapeutics.

Statement by Anthony S. Fauci, M.D. Dr. Fauci announces he is stepping down.

A new type of vaccine designed to target clade C HIV demonstrated 68% efficacy when tested on rhesus macaques exposed to simian-HIV.

https://fcld.ly/m86kjux